sodium channel inhibitor (Maruho)

N/A

Report date: 2025/03/20 09:18:37
NME

Base Information

Drug Namesodium channel inhibitor (Maruho)
Drug Alias Namesodium channel inhibitor (RaQualia/Maruho)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsPainPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRaqualia Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaruho Co Ltd
Inactive CompaniesRaqualia Pharma Inc
Active IndicationsPainPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A